Thyroid Pathology Last Updated Oct 5 2006 Jamie

  • Slides: 50
Download presentation
Thyroid Pathology Last Updated Oct. 5, 2006 Jamie Tibbo Reviewed with Dr. Jane Thomas

Thyroid Pathology Last Updated Oct. 5, 2006 Jamie Tibbo Reviewed with Dr. Jane Thomas

Overview • Benign Pathology – – Hashimoto’s Thyroiditis Grave’s Disease Multi-nodular goiter Follicular Adenoma

Overview • Benign Pathology – – Hashimoto’s Thyroiditis Grave’s Disease Multi-nodular goiter Follicular Adenoma • Malignant Pathology – – Papillary Carcinoma Follicular Carcinoma Medullary Carcinoma Anaplastic Carcinoma

Normal thyroid tissue • Normal thyroid tissue with follicles filled with colloid. • Thyroid

Normal thyroid tissue • Normal thyroid tissue with follicles filled with colloid. • Thyroid cells form follicles, spheres of epithelial cells (always single-layered in health, usually more-or-less cuboidal, variably tall or short). • The C-cells (parafollicular cells) of the thyroid are visible between the follicles

Normal thyroid tissue

Normal thyroid tissue

Hashimoto’s Thyroiditis • an autoimmune disease in which the immune system reacts against a

Hashimoto’s Thyroiditis • an autoimmune disease in which the immune system reacts against a variety of thyroid antigens • overriding feature of is progressive depletion of thyroid epithelial cells (thyrocytes), which are gradually replaced by mononuclear cell infiltration and fibrosis

Hashimoto’s-Pathogenesis • Sensitization of autoreactive CD 4+ T-helper cells to thyroid antigens appears to

Hashimoto’s-Pathogenesis • Sensitization of autoreactive CD 4+ T-helper cells to thyroid antigens appears to be the initiating event. The effector mechanisms for thyrocyte death include the following: – CD 8+ cytotoxic T cell-mediated cell death: CD 8+ cytotoxic T cells may cause thyrocyte destruction by one of two pathways: exocytosis of perforin/granzyme granules or engagement of death receptors, specifically CD 95 (also known as Fas) on the target cell – Cytokine-mediated cell death: CD 4+ T cells produce inflammatory cytokines such as IFN-γ in the immediate thyrocyte milieu, with resultant recruitment and activation of macrophages and damage to follicles. – Binding of antithyroid antibodies (anti-TSH receptor antibodies, antithyroglobulin, and antithyroid peroxidase antibodies) followed by antibody-dependent cell-mediated cytotoxicity (ADCC) Reference: Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7 th ed. , Copyright © 2005 Saunders

Hashimoto’s- Pathogenesis Reference: Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7 th ed.

Hashimoto’s- Pathogenesis Reference: Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7 th ed. , Copyright © 2005 Saunders

Hashimoto’s Thyroiditis • Lymphocytic infiltrate in the thyroid, with lymphoid follicle formation and fibrosis.

Hashimoto’s Thyroiditis • Lymphocytic infiltrate in the thyroid, with lymphoid follicle formation and fibrosis. • Presence of oncocytes-always has oncocytic metaplasia

Hashimoto’s Thyroiditis Reference: Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7 th ed.

Hashimoto’s Thyroiditis Reference: Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7 th ed. , Copyright © 2005 Saunders

Grave’s Disease

Grave’s Disease

Multi-nodular Goiter

Multi-nodular Goiter

Follicular Adenoma • adenomas are not forerunners of cancer except in rare instances •

Follicular Adenoma • adenomas are not forerunners of cancer except in rare instances • small proportion produce thyroid hormones and cause clinically apparent thyrotoxicosis • Typically a solitary, spherical, encapsulated lesion that is well demarcated from the surrounding thyroid parenchyma

Follicular Adenoma Gross Specimen

Follicular Adenoma Gross Specimen

Follicular Adenoma Microscopic • Microscopically, the constituent cells often form uniform-appearing follicles that contain

Follicular Adenoma Microscopic • Microscopically, the constituent cells often form uniform-appearing follicles that contain colloid • The follicular growth pattern within the adenoma is usually quite distinct from the adjacent non-neoplastic thyroid – distinguishing feature b/w adenomas and MNG- nodular and uninvolved thyroid parenchyma may have similar growth patterns

Follicular Adenoma Microscopic • Mitotic figures are rare • papillary change is not a

Follicular Adenoma Microscopic • Mitotic figures are rare • papillary change is not a typical feature of adenomas and, if extensive, should raise the suspicion of an encapsulated papillary carcinoma • Occasionally, the neoplastic cells acquire brightly eosinophilic granular cytoplasm (oxyphil or Hürthle cell change)

Follicular Adenoma Microscopic • Follicular adenoma H/E preparation x 100 • Follicular carcinoma account

Follicular Adenoma Microscopic • Follicular adenoma H/E preparation x 100 • Follicular carcinoma account for less than 10%

Follicular Adenoma Microscopic • well-differentiated follicles resembling normal thyroid parenchyma

Follicular Adenoma Microscopic • well-differentiated follicles resembling normal thyroid parenchyma

Follicular Adenoma with Oncocytic or Hurthle Cell Change • Also known as: – Hurthle

Follicular Adenoma with Oncocytic or Hurthle Cell Change • Also known as: – Hurthle Cell Adenoma • Occasionally, the neoplastic cells acquire brightly eosinophilic granular cytoplasm (oxyphil or Hürthle cell change) – Eosinophilic granules due to enlarged, bizarre mitochondria

Follicular Adenoma with Oncocytic or Hurthle Cell Change

Follicular Adenoma with Oncocytic or Hurthle Cell Change

Thyroid Neoplasms with Follicular Architecture • Non-Neoplastic: – Hyperplastic nodule in Goiter • Neoplastic:

Thyroid Neoplasms with Follicular Architecture • Non-Neoplastic: – Hyperplastic nodule in Goiter • Neoplastic: – Follicular adenoma – Follicular carcinoma – Follicular variant Papillary carcinoma

Papillary Thyroid Carcinoma • solitary or multifocal lesions • Some tumors well-circumscribed and encapsulated;

Papillary Thyroid Carcinoma • solitary or multifocal lesions • Some tumors well-circumscribed and encapsulated; others infiltrate the adjacent parenchyma with ill-defined margins • may contain areas of fibrosis and calcification and are often cystic

Papillary Thyroid Carcinoma • can contain branching papillae having a fibrovascular stalk covered by

Papillary Thyroid Carcinoma • can contain branching papillae having a fibrovascular stalk covered by a single to multiple layers of cuboidal epithelial cells • NUCLEI of papillary carcinoma cells contain finely dispersed chromatin, which imparts an optically clear or empty appearance, giving rise to the designation ground glass or Orphan Annie eye nuclei • invaginations of the cytoplasm may in cross-sections give the appearance of intranuclear inclusions ("pseudo-inclusions") or intranuclear grooves

Papillary Thyroid Carcinoma • the diagnosis of papillary carcinoma is based on these nuclear

Papillary Thyroid Carcinoma • the diagnosis of papillary carcinoma is based on these nuclear features even in the absence of papillary architecture. • Concentrically calcified structures termed psammoma bodies are often present within the lesion, usually within the cores of papillae – These structures are almost never found in follicular and medullary carcinomas, and so, when present, they are a strong indication that the lesion is a papillary carcinoma – whenever a psammoma body is found within a lymph node or perithyroidal tissues, a hidden papillary carcinoma must be considered

Papillary Thyroid Carcinoma • Foci of lymphatic invasion by tumor are often present, but

Papillary Thyroid Carcinoma • Foci of lymphatic invasion by tumor are often present, but involvement of blood vessels is relatively uncommon • Metastases to adjacent cervical lymph nodes are estimated to occur in up to half the cases ? ? ?

Papillary Thyroid Carcinoma

Papillary Thyroid Carcinoma

Papillary Thyroid Cancer • calcified sphere, or psammoma body • Papillary thyroid carcinoma accounts

Papillary Thyroid Cancer • calcified sphere, or psammoma body • Papillary thyroid carcinoma accounts for about 80% of all thyroid carcinomas

Papillary Thyroid Cancer • Psammoma body within a papillary cancer. • large clear areas

Papillary Thyroid Cancer • Psammoma body within a papillary cancer. • large clear areas within the nuclei which look like "Little Orphan Annie" eyes are circled in blue. • Although these nuclear features are characteristic of papillary carcinoma, they are not pathognomonic • Papillary cancer (low resolution). Notice the frondlike projections.

Papillary Thyroid Carcinoma Ground Glass Nuclei

Papillary Thyroid Carcinoma Ground Glass Nuclei

Papillary Thyroid Carcinoma Psammoma Body

Papillary Thyroid Carcinoma Psammoma Body

Papillary Thyroid Cancer- Variants • Encapsulated variant – constitutes about 10% of all papillary

Papillary Thyroid Cancer- Variants • Encapsulated variant – constitutes about 10% of all papillary neoplasms – has an excellent prognosis • Follicular variant – has the characteristic nuclei of papillary carcinoma but has an almost totally follicular architecture • Tall cell variant – tall columnar cells with intensely eosinophilic cytoplasm lining the papillary structures – Occur in older individuals and are usually large with prominent vascular invasion, extrathyroidal extension, and cervical and distant metastases

Papillary Thyroid Cancer- Variants • Diffuse sclerosing variant – occurs in younger individuals, including

Papillary Thyroid Cancer- Variants • Diffuse sclerosing variant – occurs in younger individuals, including children. These tumors do not present with a mass, but rather with a bilateral goiter – nodal metastases are present in almost all cases • Hyalizing trabecular tumors – includes both adenomas and carcinomas, have recently been reconsidered as a variant of papillary carcinomas, based on the presence of ret/PTC gene rearrangements in 30% to 60% of these tumors

Follicular Thyroid Carcinoma • 2 nd most common thyroid cancer – 10% to 20%

Follicular Thyroid Carcinoma • 2 nd most common thyroid cancer – 10% to 20% of all thyroid cancers • tend to present in women, and at an older age than do papillary carcinomas – peak incidence in the forties and fifties • incidence increased in areas of dietary iodine deficiency, suggesting that in some cases, nodular goiter may predispose to the development of the neoplasm • high frequency of RAS mutations in follicular adenomas and carcinomas suggests that the two may be related tumors

Follicular Thyroid Carcinoma Gross Specimen • Tumor has light-tan appearance • Contains small foci

Follicular Thyroid Carcinoma Gross Specimen • Tumor has light-tan appearance • Contains small foci of hemorrhage

Follicular Thyroid Carcinoma Microscopic Features • Most composed of fairly uniform cells forming small

Follicular Thyroid Carcinoma Microscopic Features • Most composed of fairly uniform cells forming small follicles containing colloid appearance of normal thyroid • In other cases, follicular differentiation may be less apparent – may be nests or sheets of cells without colloid • Occasional tumors are dominated by cells with abundant granular, eosinophilic cytoplasm (Hürthle cells). • nuclei lack the features typical of papillary carcinoma • psammoma bodies are NOT present

Follicular Thyroid Carcinoma Microscopic Features • Follicular lesions with nuclear features typical of papillary

Follicular Thyroid Carcinoma Microscopic Features • Follicular lesions with nuclear features typical of papillary carcinomas should be treated as papillary cancers • Nuclear features NOT helpful in distinguishing follicular adenomas from minimally invasive follicular carcinomas – Requires extensive sampling of the tumor-thyroid capsule interface to exclude capsular or vascular invasion. • the presence of tumor plugs within intratumoral blood vessels has little prognostic significance • Unlike in papillary cancers, lymphatic spread is distinctly uncommon in follicular cancers

Follicular Thyroid Carcinoma

Follicular Thyroid Carcinoma

Follicular Thyroid Carcinoma Follicular Adenoma Follicular Carcinoma • No Capsular invasion • Compressed normal

Follicular Thyroid Carcinoma Follicular Adenoma Follicular Carcinoma • No Capsular invasion • Compressed normal thyroid usu. present external to capsule • Capsular invasion present • May have vascular invasion

Medullary Thyroid Cancer (MTC) • arise from the parafollicular C cells in the thyroid

Medullary Thyroid Cancer (MTC) • arise from the parafollicular C cells in the thyroid • Familial medullary thyroid carcinomas occur in multiple endocrine neoplasia type 2 (MEN-2) and are associated with germ-line RET protooncogene mutations • RET mutations are detectable in approximately 95% of families with MEN-2; in the remaining few cases, the mutations may arise in hard-to-detect promoter sequences or intronic sites. • RET mutations are also seen in nonfamilial (sporadic) medullary thyroid cancers. • Chromosomal rearrangements involving RET, such as the ret/PTC translocations reported in papillary cancers, are not seen in medullary carcinomas.

Medullary Thyroid Carcinoma Gross Specimen • Solid pattern of growth • Do not have

Medullary Thyroid Carcinoma Gross Specimen • Solid pattern of growth • Do not have connective tissue capsules

Medullary Thyroid Carcinoma Microscopic Features • Immunohistochemical anti-calcitonin antibody stain of a medullary carcinoma

Medullary Thyroid Carcinoma Microscopic Features • Immunohistochemical anti-calcitonin antibody stain of a medullary carcinoma showing strong red positivity

Medullary Thyroid Carcinoma Microscopic Features • composed of polygonal to spindle-shaped cells – may

Medullary Thyroid Carcinoma Microscopic Features • composed of polygonal to spindle-shaped cells – may form nests, trabeculae, and even follicles • Small, more anaplastic cells are present in some tumors and may be the predominant cell type • Acellular amyloid deposits, derived from altered calcitonin molecules, are present in the adjacent stroma in many cases • Electron microscopy reveals variable numbers of membrane-bound electron-dense granules within the cytoplasm of the neoplastic cells.

Medullary Thyroid Carcinoma Microscopic Features • Familial medullary cancers – presence of multicentric C-cell

Medullary Thyroid Carcinoma Microscopic Features • Familial medullary cancers – presence of multicentric C-cell hyperplasia in the surrounding thyroid parenchyma, a feature that is usually absent in sporadic lesions

Medullary Thyroid Carcinoma Microscopic Features • Amyloid stroma

Medullary Thyroid Carcinoma Microscopic Features • Amyloid stroma

Medullary Thyroid Carcinoma Microscopic Features

Medullary Thyroid Carcinoma Microscopic Features

Medullary Thyroid Carcinoma Microscopic Features

Medullary Thyroid Carcinoma Microscopic Features

Anaplastic Carcinoma • undifferentiated tumors of the thyroid follicular epithelium • aggressive tumors •

Anaplastic Carcinoma • undifferentiated tumors of the thyroid follicular epithelium • aggressive tumors • mortality rate approaching 100% • fewer than 5% of all thyroid cancers • Mean Age = 65 yrs • half of the patients have a history of multinodular goiter • 20% of the patients with these tumors have a history of differentiated carcinoma • 20% to 30% have a concurrent differentiated thyroid tumor, frequently a papillary carcinoma

Anaplastic Thyroid Carcinoma Microscopic Features • highly anaplastic cells, which may take one of

Anaplastic Thyroid Carcinoma Microscopic Features • highly anaplastic cells, which may take one of several histologic patterns: 1. large, pleomorphic giant cells, including occasional osteoclast-like multinucleate giant cells 2. spindle cells with a sarcomatous appearance; 3. mixed spindle and giant cells; and 4. small cells resembling those seen in small cell carcinomas arising at other sites.

Anaplastic Thyroid Carcinoma Microscopic Features • Anaplastic carcinoma histology H/E preparation x 200

Anaplastic Thyroid Carcinoma Microscopic Features • Anaplastic carcinoma histology H/E preparation x 200